Keywords: ec, oks, isentress, treatment-experienced, hiv-1, patients, merck

EC OKs Isentress for treatment-experienced HIV-1 patients

Article | 07 January 2008

Print This

Merck, Sharp & Dohme, the UK subsidiary of US drug major Merck & Co, says that the European Commission has approved Isentress ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in